Overview on the chemistry and immunomodulating properties of novel pyrimidinones.
Wierenga
W
W
Parke-Davis Pharmaceutical Research Division, Ann Arbor, Michigan 48105-2430.
D000276:Adjuvants, Immunologic / Q000737:chemistry / Q000494:pharmacology*; D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D003596:Cytosine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000494:pharmacology; D006801:Humans
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D003596:Cytosine; C033560:bropirimine